Age-dependent effects of milrinone and levosimendan on ventricular function and haemodynamics in newborn and mature pigs

Cardiology in the Young

Volumn 21, Issue 5, 2011, Pages 518-527

  Hyldebrandt, Janus A ^a   Larsen, Signe H ^a   Schmidt, Michael R ^a   Hjortdal, Vibeke E ^a   Ravn, Hanne B ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

cardiac output; haemodynamics; infant; Levosimendan; low; milrinone; myocardial contraction; newborn

Indexed keywords

LEVOSIMENDAN; MILRINONE; PLACEBO; RINGER ACETATE; CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN; VASODILATOR AGENT;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL VENOUS PRESSURE; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG EFFECT; HEART HEMODYNAMICS; HEART INDEX; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONTRACTILITY; HEART OUTPUT MEASUREMENT; HEART PRELOAD; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE CONTRACTILITY; HEART VENTRICLE FUNCTION; HEART VENTRICLE OVERLOAD; HEART VENTRICLE PRESSURE; IN VIVO STUDY; LOADING DRUG DOSE; MEAN ARTERIAL PRESSURE; NEWBORN; NONHUMAN; SWINE; SYSTEMIC VASCULAR RESISTANCE; SYSTOLIC BLOOD PRESSURE; ANIMAL; HEMODYNAMICS;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; CARDIOTONIC AGENTS; HEMODYNAMICS; HYDRAZONES; MILRINONE; PYRIDAZINES; SWINE; VASODILATOR AGENTS; VENTRICULAR FUNCTION;

EID: 84856341408     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951111000357     Document Type: Article

References (32)

1. Hoffman TM, Wernovsky G, Atz AM, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003; 107: 996-1002. (Pubitemid 36258723)
2. Bailey JM, Miller BE, Lu W, et al. The pharmacokinetics of milrinone in pediatric patients after cardiac surgery. Anesthesiology 1999; 90: 1012-1018. (Pubitemid 29159758)
3. Stocker CF, Shekerdemian LS, Norgaard MA, et al. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass. Crit Care Med 2007; 35: 252-259. (Pubitemid 46035703)
4. Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised doubleblind trial. Lancet 2002; 360: 196-202. (Pubitemid 34804646)
5. Caspi J, Coles JG, Benson LN, et al. Heart rate independence of catecholamine-induced myocardial damage in the newborn pig. Pediatr Res 1994; 36: 49-54. (Pubitemid 24185187)
6. Fowler MB, Alderman EL, Oesterle SN, et al. Dobutamine and dopamine after cardiac surgery: greater augmentation of myocardial blood flow with dobutamine. Circulation 1984; 70: I103-I111.
7. Wittnich C, Belanger MP, Bandali K. Are there ventricle-specific postnatal maturational differences in myocardial beta-adrenoceptors? Can J Physiol Pharmacol 2006; 84: 859-865. (Pubitemid 46132210)
8. Tanaka H, Shigenobu K. Role of beta-adrenoceptor-adenylate cyclase system in the developmental decrease in sensitivity to isoprenaline in foetal and neonatal rat heart. Br J Pharmacol 1990; 100: 138-142. (Pubitemid 20161443)
9. Shaddy RE, Tyndall MR, Teitel DF, Li C, Rudolph AM. Regulation of cardiac output with controlled heart rate in newborn lambs. Pediatr Res 1988; 24: 577-582. (Pubitemid 18266166)
10. Paradisis M, Evans N, Kluckow M, Osborn D. Randomized trial of milrinone versus placebo for prevention of low systemic blood flow in very preterm infants. J Pediatr 2009; 154: 189-195.
11. Egan JR, Clarke AJ, Williams S, et al. Levosimendan for low cardiac output: a pediatric experience. J Intensive Care Med 2006; 21: 183-187.
12. Namachivayam P, Crossland DS, Butt WW, Shekerdemian LS. Early experience with levosimendan in children with ventricular dysfunction. Pediatr Crit Care Med 2006; 7: 445-448. (Pubitemid 44386070)
13. Baan J, van der Velde ET, de Bruin HG, et al. Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation 1984; 70: 812-823. (Pubitemid 15205446)
14. Weiss JL, Frederiksen JW, Weisfeldt ML. Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J Clin Invest 1976; 58: 751-760.
15. Glower DD, Spratt JA, Snow ND, et al. Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation 1985; 71: 994-1009. (Pubitemid 15035251)
16. Segreti JA, Marsh KC, Polakowski JS, Fryer RM. Evoked changes in cardiovascular function in rats by infusion of levosimendan, OR-1896 [(R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one], dobutamine, and milrinone: comparative effects on peripheral resistance, cardiac output, dP/dt, pulse rate, and blood pressure. J Pharmacol Exp Ther 2008; 325: 331-340. (Pubitemid 351439154)
17. Banfor PN, Preusser LC, Campbell TJ, et al. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs. Am J Physiol Heart Circ Physiol 2008; 294: H238-H248.
18. Bailey JM, Hoffman TM, Wessel DL, et al. A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery. J Pharmacokinet Pharmacodyn 2004; 31: 43-59. (Pubitemid 38870189)
19. Feneck RO. Milrinone and postoperative pulmonary hypertension. J Cardiothorac Vasc Anesth 1993; 7: 21-23. (Pubitemid 23111830)
20. Chang AC, Atz AM, Wernovsky G, Burke RP, Wessel DL. Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med 1995; 23: 1907-1914.
21. Sys SU, Goenen MJ, Chalant CH, Brutsaert DL. Inotropic effects of amrinone and milrinone on contraction and relaxation of isolated cardiac muscle. Circulation 1986; 73: III25-III35.
22. Leather HA, Ver EK, Segers P, et al. Effects of levosimendan on right ventricular function and ventriculovascular coupling in open chest pigs. Crit Care Med 2003; 31: 2339-2343. (Pubitemid 37100837)
23. Binah O, Legato MJ, Danilo Jr P, Rosen MR. Developmental changes in the cardiac effects of amrinone in the dog. Circ Res 1983; 52: 747-752. (Pubitemid 13073655)
24. Klitzner TS, Shapir Y, Ravin R, Friedman WF. The biphasic effect of amrinone on tension development in newborn mammalian myocardium. Pediatr Res 1990; 27: 144-147. (Pubitemid 20044532)
25. Ross-Ascuitto N, Ascuitto R, Chen V, Downing SE. Negative inotropic effects of amrinone in the neonatal piglet heart. Circ Res 1987; 61: 847-852. (Pubitemid 18004580)
26. Ross-Ascuitto NT, Ascuitto RJ, Ramage D, McDonough KH. The effects of milrinone in the neonatal pig heart. Cardiovasc Drugs Ther 1991; 5: 1011-1019.
27. Binah O, Sodowick B, Vulliemoz Y, Danilo P Jr, Rosen M. The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle. Circulation 1986; 73: III46-III51.
28. Akita T, Joyner RW, Lu C, Kumar R, Hartzell HC. Developmental changes in modulation of calcium currents of rabbit ventricular cells by phosphodiesterase inhibitors. Circulation 1994; 90: 469-478. (Pubitemid 24203714)
29. Seguchi M, Harding JA, Jarmakani JM. Developmental change in the function of sarcoplasmic reticulum. J Mol Cell Cardiol 1986; 18: 189-195. (Pubitemid 16165810)
30. Lechner E, Moosbauer W, Pinter M, Mair R, Tulzer G. Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate. Pediatr Crit Care Med 2006; 8: 61-63. (Pubitemid 46168361)
31. Feneck RO, Sherry KM, Withington PS, Oduro-Dominah A. Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J Cardiothorac Vasc Anesth 2001; 15: 306-315. (Pubitemid 32553377)
32. Joynt C, Bigam DL, Charrois G, et al. Dose-response effects of milrinone on hemodynamics of newborn pigs with hypoxiareoxygenation. Intensive Care Med 2008; 34: 1321-1329. (Pubitemid 351904297)